Clinical Trials Logo
  1. Home
  2. Infertility
  3. NCT04778319
  4. Details
NCT04778319 Clinical Trial

Hysterosalpingography and Hysteroscopy in ICSI

Infertility Clinical Trial

Official title:
Hysterosalpingography and Hysteroscopy in Intracytoplasmic Sperm Injection

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT04778319
Other study ID # tubal disease
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 2, 2021
Est. completion date February 15, 2022

Study information
Verified date February 2021
Source Aljazeera Hospital
Contact Mahmoud Alalfy
Phone 01002611058
Email mahmoudalalfy@ymail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

unexplained infertility is a rising problem in clinical practice

Description:

Assessment of uterine cavity is very important before ICSI

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 200
Est. completion date February 15, 2022
Est. primary completion date February 1, 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 42 Years
Eligibility Inclusion Criteria: - women with infertility Exclusion Criteria: - women with medical disorders

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• occlusion of tubes
to occlude the fallopian tubes
• non occlusion of tubes
not to occlude the tubes

Locations
Country Name City State
Egypt Aljazeera( Al Gazeera) hospital Giza

Sponsors (1)
Lead Sponsor Collaborator
Aljazeera Hospital

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary the number of women who will become pregnant number of women who will have positive pregnancy test 3 months
See also
  Status Clinical Trial Phase
Completed NCT03607409 - Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
Recruiting NCT02312076 - GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles Phase 4
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Completed NCT03287479 - Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®) N/A
Terminated NCT03522350 - Randomized Trial Comparing EmbryoScope With EmbryoScope+. N/A
Completed NCT04496284 - Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen N/A
Completed NCT03623659 - pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts N/A
Completed NCT03895099 - New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors Phase 3
Active, not recruiting NCT04142112 - Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation N/A
Completed NCT03152643 - Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer N/A
Recruiting NCT03683771 - Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
Recruiting NCT03161119 - Comparing Two Different Embryo Transfer Catheters N/A
Completed NCT04108039 - Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles. N/A
Completed NCT03678597 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB) N/A
Completed NCT03678571 - Oocyte Vitrification Aided With Latrunculin A N/A
Completed NCT03678584 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA) N/A
Completed NCT03678558 - Oocyte Vitrification Aided With Cytochalasin B N/A
Completed NCT03678610 - Handling Medium for ICSI With Ionomycin and Latrunculin A N/A
Completed NCT03678818 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA) N/A
Completed NCT03677492 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD) N/A